| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 4e-05 |